![Karl Härfstrand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Härfstrand
Directeur/Membre du Conseil chez
KDVENTURES AB
Profil
Karl Anders Olof Härfstrand is the founder of Härfstrand Consulting AG, serving as Chairman since 2010.
Current job includes Director at Karolinska Development AB since 2025.
Former jobs include President & Chief Executive Officer-Europe at ADAMA Agricultural Solutions Ltd. from 2013 to 2014, Chief Executive Officer & Director at Horizon Therapeutics Switzerland GmbH from 2007 to 2010, Chief Executive Officer at to-BBB Holding BV from 2014 to 2015, Chief Executive Officer at to-BBB technologies BV from 2014 to 2015, President & Chief Executive Officer at ADAMA Agriculture BV from 2013 to 2014, President & Chief Executive Officer at Humabs BioMed SA from 2011 to 2012, Independent Non-Executive Chairman at Vivesto AB from 2020 to 2022, Non-Executive Chairman at Neurocrine Group Ltd. from 2021 to 2022, Chairman at Brain+ A from 2022 to 2024, Director at Acino International AG from 2008 to 2013, Director at Ascenditur AB, Director at OphthalmoPharma AG, Director at HeiQ Materials AG, Director & Executive Vice President at Pfizer Japan, Inc. in 2005, Independent Director at Karolinska Development AB from 2017 to 2019, Independent Director at Prothena Corp.
Plc from 2015 to 2024, Vice President-Country Operations at Pharmacia & Upjohn, Inc. from 1988 to 2003, Vice President-Country Operations at Pharmacia AB from 1988 to 2003, Senior Executive Vice President at EMD Serono, Inc. from 2005 to 2007, Principal at Pharmacia, Inc. in 2003, and Senior Executive Vice President at Serono International SA in 2010.
Education includes a doctorate from Karolinska Institutet, conferred in 1987.
Postes actifs de Karl Härfstrand
| Sociétés | Poste | Début |
|---|---|---|
| KDVENTURES AB | Directeur/Membre du Conseil | 01/05/2025 |
Härfstrand Consulting AG
 Härfstrand Consulting AG Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Fondateur | 01/08/2010 |
Anciens postes connus de Karl Härfstrand
| Sociétés | Poste | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Directeur/Membre du Conseil | 14/05/2024 |
| BRAIN+ A/S | Président | 31/01/2024 |
| VIVESTO AB | Président | 25/05/2022 |
| DIUL GROUP | Président | 01/01/2022 |
| KDVENTURES AB | Directeur/Membre du Conseil | 01/01/2019 |
Formation de Karl Härfstrand
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Ascenditur AB
 Ascenditur AB Medical SpecialtiesHealth Technology Manufactures irradiation, electro medical, and electrotherapeutic equipment | Health Technology |
ADAMA Agricultural Solutions Ltd.
 ADAMA Agricultural Solutions Ltd. Chemicals: AgriculturalProcess Industries Develops, manufactures and markets crop & non-crop protection products | Process Industries |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Pharmacia, Inc. | |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes therapeutics for neuropsychiatric, neurological & neuroendocrine disorders | Health Technology |
OphthalmoPharma AG
 OphthalmoPharma AG Medical SpecialtiesHealth Technology Develops ophthalmology treatments | Health Technology |
HeiQ Materials AG
 HeiQ Materials AG TextilesProcess Industries Develops and manufactures antimicrobial silver and sustainable textile effects | Process Industries |
ADAMA Agriculture BV
 ADAMA Agriculture BV Chemicals: AgriculturalProcess Industries Manufactures biocidal products for crop protection | Process Industries |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets medical drugs & vaccines | Commercial Services |
Serono International SA | |
Härfstrand Consulting AG
Härfstrand Consulting AG Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Develops human monoclonal antibodies for treatment of infectious and inflammatory diseases | Commercial Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Brain+ A/S
 Brain+ A/S Packaged SoftwareTechnology Services Develops medical software to detect and treat the cognitive symptoms of dementia | Technology Services |
